“The buying-up of remdesivir is disappointing news, not necessarily because of the shortages it implies for other countries, but because it so clearly signals an unwillingness to co-operate with other countries, and the chilling effect this has on international agreements about intellectual property rights,” Ohid Yaqub, a senior lecturer at the University of Sussex in England, said in a statement Wednesday.
Experts slam U.S. decision to buy nearly entire global supply of coronavirus drug remdesivir
Prepare Now Before its too Late
Discover where products are available & compare prices
